Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Greene

Showing results (391-400 of 410) with videos related to

Pageof 41
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKDWillem Collier, Lesley A Inker, Benjamin Haaland, et al.
Nature Medicine|November 6, 2025
A meta-analysis of albuminuria as a surrogate endpoint for kidney failureHiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, et al.
Transplantation and Cellular Therapy|September 19, 2025
Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy ConsortiumKaren Sweiss, Charlotte Wagner, Eric Anto, et al.
Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.
American Journal of Public Health|October 2, 2024
Reach and Engagement With Population Health Management Interventions to Address COVID-19 Among Safety-Net Health Care SystemsChelsey R Schlechter, Tatyana V Kuzmenko, Brian Orleans, et al.
The New England Journal of Medicine|November 25, 2010
In-center hemodialysis six times per week versus three times per week, Glenn M Chertow, Nathan W Levin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2018
Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK WorkshopAnna Zuk, Paul M Palevsky, Linda Fried, et al.
BMJ Open|March 20, 2024
SCALE-UP II: protocol for a pragmatic randomised trial examining population health management interventions to increase the uptake of at-home COVID-19 testing in community health centresGuilherme Del Fiol, Brian Orleans, Tatyana V Kuzmenko, et al.
Nature Medicine|June 17, 2023
A meta-analysis of GFR slope as a surrogate endpoint for kidney failureLesley A Inker, Willem Collier, Tom Greene, et al.
Journal of the American Society of Nephrology : JASN|December 4, 2021
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease ProgressionBrendon L Neuen, Hocine Tighiouart, Hiddo J L Heerspink, et al.
Pageof 41

Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKDWillem Collier, Lesley A Inker, Benjamin Haaland, et al.
Nature Medicine|November 6, 2025
A meta-analysis of albuminuria as a surrogate endpoint for kidney failureHiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, et al.
Transplantation and Cellular Therapy|September 19, 2025
Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy ConsortiumKaren Sweiss, Charlotte Wagner, Eric Anto, et al.
Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.
American Journal of Public Health|October 2, 2024
Reach and Engagement With Population Health Management Interventions to Address COVID-19 Among Safety-Net Health Care SystemsChelsey R Schlechter, Tatyana V Kuzmenko, Brian Orleans, et al.
The New England Journal of Medicine|November 25, 2010
In-center hemodialysis six times per week versus three times per week, Glenn M Chertow, Nathan W Levin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2018
Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK WorkshopAnna Zuk, Paul M Palevsky, Linda Fried, et al.
BMJ Open|March 20, 2024
SCALE-UP II: protocol for a pragmatic randomised trial examining population health management interventions to increase the uptake of at-home COVID-19 testing in community health centresGuilherme Del Fiol, Brian Orleans, Tatyana V Kuzmenko, et al.
Nature Medicine|June 17, 2023
A meta-analysis of GFR slope as a surrogate endpoint for kidney failureLesley A Inker, Willem Collier, Tom Greene, et al.
Journal of the American Society of Nephrology : JASN|December 4, 2021
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease ProgressionBrendon L Neuen, Hocine Tighiouart, Hiddo J L Heerspink, et al.
Pageof 41